Efficacy of oral vancomycin in primary prevention of Clostridium Difficile infection in elderly patients treated with systemic antibiotic therapy

被引：12
|
作者：
Papic, Neven [1 ]
Maric, Lorna Stemberger [1 ,2 ]
Vince, Adriana [1 ,3 ]
机构：
[1] Univ Hosp Infect Dis, Zagreb, Croatia
[2] Univ Zagreb, Sch Dent Med, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Zagreb, Croatia
来源：
INFECTIOUS DISEASES | 2018年 / 50卷 / 06期
关键词：
RESISTANT ENTEROCOCCI; METRONIDAZOLE; EPIDEMIOLOGY; DISEASE; ADULTS;
D O I：
10.1080/23744235.2018.1425551
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：483 / 486
页数：4
相关论文
共 50 条
  • [11] Risk Factors for Systemic Vancomycin Exposure Following Administration of Oral Vancomycin for the Treatment of Clostridium difficile Infection
    Pettit, Natasha N.
    DePestel, Daryl D.
    Fohl, Alexander L.
    Eyler, Rachel
    Carver, Peggy L.
    PHARMACOTHERAPY, 2015, 35 (02): : 119 - 126
  • [12] Oral Vancomycin for Secondary Prophylaxis of Clostridium difficile Infection
    Brown, Chase C.
    Manis, Melanie M.
    Bohm, Nicole M.
    Curry, Scott R.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (04) : 396 - 401
  • [13] Long-Term Efficacy of Oral Vancomycin Prophylaxis for the Prevention of Clostridium difficile Recurrence
    Knight, Emmanuel M.
    Schiller, Daryl S.
    Fulman, Magda K.
    Rastogi, Rupangi
    JOURNAL OF PHARMACY PRACTICE, 2020, 33 (05) : 633 - 639
  • [14] Outcomes from Rectal Vancomycin Therapy in Patients With Clostridium difficile Infection
    Saffouri, George
    Khanna, Sahil
    Estes, Lynn
    Pardi, Darrell
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (06): : 924 - 925
  • [15] Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure
    Johnson, Steven W.
    Brown, Shannon, V
    Priest, David H.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (05) : 1133 - 1139
  • [16] Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients
    Splinter, Lindsey E.
    Kerstenetzky, Luiza
    Jorgenson, Margaret R.
    Descourouez, Jillian L.
    Leverson, Glen E.
    Saddler, Christopher M.
    Smith, Jeannina A.
    Safdar, Nasia
    Redfield, Robert R.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (02) : 113 - 119
  • [17] Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection
    Hung, Yuan-Pin
    Lin, Hsiao-Ju
    Wu, Chi-Jung
    Chen, Po-Lin
    Lee, Jen-Chieh
    Liu, Hsiao-Chieh
    Wu, Yi-Hui
    Yeh, Fang Hao
    Tsai, Pei-Jane
    Ko, Wen-Chien
    ANAEROBE, 2014, 30 : 24 - 26
  • [18] TREATMENT OF ANTIBIOTIC-ASSOCIATED CLOSTRIDIUM DIFFICILE DIARRHEA WITH ORAL VANCOMYCIN
    BATTS, DH
    MARTIN, D
    HOLMES, R
    SILVA, J
    FEKETY, FR
    JOURNAL OF PEDIATRICS, 1980, 97 (01): : 151 - 153
  • [19] Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient
    Mahabir, Shanti
    Lim, Ren Yik
    Fitzpatrick, Fidelma
    Magee, Colm
    Keogan, Mary
    WORLD ALLERGY ORGANIZATION JOURNAL, 2013, 6
  • [20] Impact of Delayed Oral Vancomycin for Severe Clostridium difficile Infection
    Shah, Sunish
    Ereshefsky, Benjamin
    Pontiggia, Laura
    Cawley, Michael
    HOSPITAL PHARMACY, 2019, 54 (05) : 294 - 299
12345